Your session is about to expire
← Back to Search
Personalized Diet for Inflammatory Bowel Disease
Study Summary
This trial tests personalized eating plans recommended by an IBD dietician to improve patient tolerance and health.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are adults being recruited for participation in this experiment?
"According to the requirements listed for eligibility, individuals aged 6-39 may partake in this trial."
Is there still capacity for participants in the current clinical trial?
"Absolutely. According to clinicaltrials.gov, this research is actively gathering participants with the trial first posted on August 1st 2023 and most recently updated November 29th 2023. This medical study needs 600 people across two sites to partake in the experiment."
How many applicants are being enrolled in this medical experiment?
"Correct. According to clinicaltrials.gov, this medical study, which was initially established on August 1st 2023, is still recruiting patients. 600 people are necessary for the trial and it will be conducted at 2 separate sites."
Are there any restrictions on who can participate in this medical research?
"This clinical trial is on the hunt for 600 participants presenting with inflammatory bowel disease, aged between 6 and 39. The most pertinent requirements are: a diagnosis of UC or IBDU, remission-mild-moderate Mayo score under 10, no changes in biologics/immunomodulators within the month prior to enrolment as well as evidence that they can collect all samples & provide data. Two control groups will be established - non-IBD patients undergoing colonoscopy who don't have IBD; healthy individuals without any GI symptoms (not required to undertake colonoscopy) such as family members - both age ranges spanning"
Share this study with friends
Copy Link
Messenger